A Phase 2 Single Arm Study to Examine the Effects of Metformin on Cancer Metabolism in Patients With Early Stage Breast Cancer Receiving Neoadjuvant Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 02 Sep 2015
At a glance
- Drugs Metformin (Primary)
- Indications Advanced breast cancer
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 01 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Dec 2013 Accrual to date is 110% according to United Kingdom Clinical Research Network record.